Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Jaguar Health (JAGX) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $550000.0.

  • Jaguar Health's Accumulated Depreciation & Amortization rose 978.04% to $550000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $550000.0, marking a year-over-year increase of 978.04%. This contributed to the annual value of $513000.0 for FY2024, which is 1032.26% up from last year.
  • Latest data reveals that Jaguar Health reported Accumulated Depreciation & Amortization of $550000.0 as of Q3 2025, which was up 978.04% from $536000.0 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Accumulated Depreciation & Amortization ranged from a high of $550000.0 in Q3 2025 and a low of $274000.0 during Q1 2021
  • Its 5-year average for Accumulated Depreciation & Amortization is $432894.7, with a median of $450000.0 in 2023.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 5655.17% in 2022, then tumbled by 91.12% in 2023.
  • Over the past 5 years, Jaguar Health's Accumulated Depreciation & Amortization (Quarter) stood at $298000.0 in 2021, then surged by 35.57% to $404000.0 in 2022, then rose by 15.1% to $465000.0 in 2023, then increased by 10.32% to $513000.0 in 2024, then increased by 7.21% to $550000.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $550000.0 for Q3 2025, versus $536000.0 for Q2 2025 and $525000.0 for Q1 2025.